Page 129 - 2023-03-中国全科医学

·378· http: //www.chinagp.net E-mail: zgqkyx@chinagp.net.cn Jaunary 2023, Vol.26 No.3

as players and therapeutic targets in pulmonary diseases［J］. Pulm ［54］HANCOCK L A，HENNESSY C E，SOLOMON G M，et al. Muc5b
Med，2021，2021：5488591. DOI：10.1155/2021/5488591. overexpression causes mucociliary dysfunction and enhances lung
［42］LI Y N，BAO J，BIAN Y Y，et al. S100A4+ macrophages fibrosis in mice［J］. Nat Commun，2018，9（1）：5363. DOI：
are necessary for pulmonary fibrosis by activating lung 10.1038/s41467-018-07768-9.
fibroblasts［J］. Front Immunol，2018，9：1776. DOI： ［55］WANG H，ZHUANG Y，PENG H，et al. The relationship
10.3389/fimmu.2018.01776. between MUC5B promoter，TERT polymorphisms and
［43］LEE J U，CHANG H S，SHIM E Y，et al. The S100 calcium- telomere lengths with radiographic extent and survival in a
binding protein A4 level is elevated in the lungs of patients with Chinese IPF cohort［J］. Sci Rep，2019，9（1）：15307.
idiopathic pulmonary fibrosis［J］. Respir Med，2020，171： DOI：10.1038/s41598-019-51902-6.
105945. DOI：10.1016/j.rmed.2020.105945. ［56］宋永娜，王林纳，翟建霞，等 . MUC5B 启动子 rs35705950、
［44］AKIYAMA N，HOZUMI H，ISAYAMA T，et al. Clinical rs868903 基因多态性与特发性肺纤维化的相关性研究［J］.
significance of serum S100 calcium-binding protein A4 in idiopathic 临 床 肺 科 杂 志，2021，26（5）：682-686. DOI：10.3969/j.
pulmonary fibrosis［J］. Respirology，2020，25（7）：743-749. issn.1009-6663.2021.05.008.
DOI：10.1111/resp.13707. SONG Y N，WANG L N，ZHAI J X，et al. Study on the correlation
［45］HESSELSTRAND R，WILDT M，BOZOVIC G，et al. Biomarkers of the polymorphism of MUC5B promoter rs35705950 and rs868903
from bronchoalveolar lavage fluid in systemic sclerosis patients with idiopathic pulmonary fibrosis［J］. Journal of Clinical
with interstitial lung disease relate to severity of lung fibrosis［J］. Pulmonary Medicine，2021，26（5）：682-686. DOI：10.3969/j.
Respir Med，2013，107（7）：1079-1086. DOI：10.1016/j. issn.1009-6663.2021.05.008.
rmed.2013.03.015. ［57］JIANG H M，HU Y J，SHANG L，et al. Association between
［46］HARA A，SAKAMOTO N，ISHIMATSU Y，et al. S100A9 MUC5B polymorphism and susceptibility and severity of idiopathic
in BALF is a candidate biomarker of idiopathic pulmonary pulmonary fibrosis［J］. Int J Clin Exp Pathol，2015，8（11）：
fibrosis［J］. Respir Med，2012，106（4）：571-580. DOI： 14953-14958.
10.1016/j.rmed.2011.12.010. ［58］郭璐，钟振东，刘晓姝，等 . MUC5B 和 TOLLIP 基因多态性对
［47］BENNETT D，SALVINI M，FUI A，et al. Calgranulin B and 特发性肺纤维化患者预后评估的临床研究［J］. 中国呼吸与危
KL-6 in bronchoalveolar lavage of patients with IPF and NSIP［J］. 重 监 护 杂 志，2019，18（6）：543-548. DOI：10.7507/1671-
Inflammation，2019，42（2）：463-470. DOI：10.1007/s10753- 6205.201811081.
018-00955-2. GUO L，ZHONG Z D，LIU X S，et al. Clinical study of MUC5B
［48］MACHAHUA C，GULER S A，HORN M P，et al. Serum and TOLLIP gene polymorphisms in evaluating the prognosis of
calprotectin as new biomarker for disease severity in idiopathic patients with idiopathic pulmonary fibrosis［J］. Chinese Journal of
pulmonary fibrosis：a cross-sectional study in two independent Respiratory and Critical Care Medicine，2019，18（6）：543-
cohorts［J］. BMJ Open Respir Res，2021，8（1）：e000827. 548. DOI：10.7507/1671-6205.201811081.
DOI：10.1136/bmjresp-2020-000827. ［59］PELJTO A L，ZHANG Y Z，FINGERLIN T E，et al. Association
［49］SHENDEROV K，COLLINS S L，POWELL J D，et al. Immune between the MUC5B promoter polymorphism and survival in patients
dysregulation as a driver of idiopathic pulmonary fibrosis［J］. J Clin with idiopathic pulmonary fibrosis［J］. JAMA，2013，309（21）：
Invest，2021，131（2）：143226. DOI：10.1172/JCI143226. 2232-2239. DOI：10.1001/jama.2013.5827.
［50］LI Y P，HE Y W，CHEN S B，et al. S100A12 as biomarker of ［60］BIONDINI D，COCCONCELLI E，BERNARDINELLO N，et al.
disease severity and prognosis in patients with idiopathic pulmonary Prognostic role of MUC5B rs35705950 genotype in patients with
fibrosis［J］. Front Immunol，2022，13：810338. DOI： idiopathic pulmonary fibrosis（IPF）on antifibrotic treatment［J］.
10.3389/fimmu.2022.810338. Respir Res，2021，22（1）：98. DOI：10.1186/s12931-021-
［51］LOMAS-NEIRA J，VENET F，CHUNG C S，et al. Neutrophil- 01694-z.
endothelial interactions mediate angiopoietin-2-associated ［61］NOTH I，ZHANG Y Z，MA S F，et al. Genetic variants associated
pulmonary endothelial cell dysfunction in indirect acute lung injury with idiopathic pulmonary fibrosis susceptibility and mortality：
in mice［J］. Am J Respir Cell Mol Biol，2014，50（1）：193- a genome-wide association study［J］. Lancet Respir Med，2013，
200. DOI：10.1165/rcmb.2013-0148OC. 1（4）：309-317. DOI：10.1016/S2213-2600（13）70045-6.
［52］UEHARA M，ENOMOTO N，MIKAMO M，et al. Impact of ［62］STERCLOVA M，KISHORE A，SIKOROVA K，et al. Effect
angiopoietin-1 and-2 on clinical course of idiopathic pulmonary of genotype on the disease course in idiopathic pulmonary fibrosis
fibrosis［J］. Respir Med，2016，114：18-26. DOI：10.1016/j. despite antifibrotic treatment［J］. Biomed Rep，2021，15（5）：
rmed.2016.03.001. 87. DOI：10.3892/br.2021.1463.
［53］白艳玲，朱海燕，孙启玉，等 . 血管生成素对特发性肺纤维化 ［63］BONELLA F，CAMPO I，ZORZETTO M，et al. Potential clinical
预后的预测价值［J］. 中华危重病急救医学，2017，29（9）： utility of MUC5B und TOLLIP single nucleotide polymorphisms
789-793. DOI：10.3760/cma.j.issn.2095-4352.2017.09.005. （SNPs）in the management of patients with IPF［J］. Orphanet
BAI Y L，ZHU H Y，SUN Q Y，et al. Clinical value of angiogenin J Rare Dis，2021，16（1）：111. DOI：10.1186/s13023-021-
in predicting the prognosis of patients with idiopathic pulmonary 01750-3.
fibrosis［J］. Chinese Critical Care Medicine 2017，29（9）： ［64］MOLINA-MOLINA M，PLANAS-CEREZALES L，PERONA
789-793. DOI：10.3760/cma.j.issn.2095-4352.2017.09.005. R. Telomere shortening in idiopathic pulmonary fibrosis［J］.